Journal of Autism and Developmental Disorders

, Volume 44, Issue 4, pp 766–775 | Cite as

Maternal Diabetes and the Risk of Autism Spectrum Disorders in the Offspring: A Systematic Review and Meta-Analysis

Original Paper

Abstract

We performed a systematic literature search regarding maternal diabetes before and during pregnancy and the risk of autism spectrum disorders (ASD) in the offspring. Of the 178 potentially relevant articles, 12 articles including three cohort studies and nine case–control studies were included in the meta-analysis. Both the meta-analyses of cohort studies and case–control studies showed significant associations. The pooled relative risk and 95 % confidence interval (CI) among cohort studies was 1.48 (1.25–1.75, p < 0.001). For case–control studies, the pooled odds ratio and 95 % CI was 1.72 (1.24–2.41, p = 0.001). No indication of significant heterogeneity across studies or publication bias was observed. In conclusion, maternal diabetes was significantly associated with a greater risk of ASD in the offspring.

Keywords

Autism spectrum disorders Diabetes Pregnancy 

Abbreviations

ADI-R

Autism diagnostic interview-revised

ADOS

The autism diagnostic observation schedule

ASD

Autism spectrum disorders

CARS

The childhood autism rating scale

CI

Confidence interval

DSM-IV

The diagnostic and statistical manual of mental disorders, fourth edition

ICD

International classification of diseases

OR

Odds ratio

RR

Relative risk

Supplementary material

10803_2013_1928_MOESM1_ESM.doc (136 kb)
Supplementary material 1 (DOC 136 kb)

References

  1. Albrecht, S. S., Kuklina, E. V., Bansil, P., Jamieson, D. J., Whiteman, M. K., Kourtis, A. P., et al. (2010). Diabetes trends among delivery hospitalizations in the US, 1994–2004. Diabetes Care, 33, 768–773.PubMedCentralPubMedCrossRefGoogle Scholar
  2. American Diabetes Association. (2004). Gestational diabetes mellitus. Diabetes Care, 27(Suppl 1), S88–S90.Google Scholar
  3. American Diabetes Association. (2013). Diagnosis and classification of diabetes mellitus. Diabetes Care, 36(Suppl 1), S67–S74.PubMedCentralCrossRefGoogle Scholar
  4. Anderson, J. L., Waller, D. K., Canfield, M. A., Shaw, G. M., Watkins, M. L., & Werler, M. M. (2005). Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiology, 16, 87–92.PubMedCrossRefGoogle Scholar
  5. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention. (2012). Prevalence of autism spectrum disorders–Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ, 61, 1–19.Google Scholar
  6. Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., et al. (1995). Autism as a strongly genetic disorder: evidence from a British twin study. Psychological Medicine, 25, 63–77.PubMedCrossRefGoogle Scholar
  7. Bardenheier, B. H., Elixhauser, A., Imperatore, G., Devlin, H. M., Kuklina, E. V., Geiss, L. S., et al. (2013). Variation in prevalence of gestational diabetes mellitus among hospital discharges for obstetric delivery across 23 states in the United States. Diabetes Care, 36, 1209–1214.PubMedCrossRefGoogle Scholar
  8. Bell, R., Bailey, K., Cresswell, T., Hawthorne, G., Critchley, J., & Lewis-Barned, N. (2008). Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG: An International Journal of Obstetrics and Gynaecology, 115, 445–452.CrossRefGoogle Scholar
  9. Biri, A., Onan, A., Devrim, E., Babacan, F., Kavutcu, M., & Durak, I. (2006). Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta, 27, 327–332.PubMedCrossRefGoogle Scholar
  10. Brimacombe, M., Ming, X., & Lamendola, M. (2007). Prenatal and birth complications in autism. Maternal and Child Health Journal, 11, 73–79.PubMedCrossRefGoogle Scholar
  11. Buchmayer, S., Johansson, S., Johansson, A., Hultman, C. M., Sparen, P., & Cnattingius, S. (2009). Can association between preterm birth and autism be explained by maternal or neonatal morbidity? Pediatrics, 124, e817–e825.PubMedCrossRefGoogle Scholar
  12. Burstyn, I., Sithole, F., & Zwaigenbaum, L. (2010). Autism spectrum disorders, maternal characteristics and obstetric complications among singletons born in Alberta, Canada. Chronic Diseases in Canada, 30, 125–134.PubMedGoogle Scholar
  13. Burstyn, I., Wang, X., Yasui, Y., Sithole, F., & Zwaigenbaum, L. (2011). Autism spectrum disorders and fetal hypoxia in a population-based cohort: accounting for missing exposures via Estimation-Maximization algorithm. BMC Medical Research Methodology, 11, 2.PubMedCentralPubMedCrossRefGoogle Scholar
  14. Chauhan, A., Chauhan, V., Brown, W. T., & Cohen, I. (2004). Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin–the antioxidant proteins. Life Sciences, 75, 2539–2549.PubMedCrossRefGoogle Scholar
  15. Chen, X., & Scholl, T. O. (2005). Oxidative stress: Changes in pregnancy and with gestational diabetes mellitus. Current Diabetes Reports, 5, 282–288.PubMedCrossRefGoogle Scholar
  16. Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., & Van de Water, J. (2005). Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: A case-control study. Archives of Pediatrics and Adolescent Medicine, 159, 151–157.PubMedCrossRefGoogle Scholar
  17. DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177–188.PubMedCrossRefGoogle Scholar
  18. Dodds, L., Fell, D. B., Shea, S., Armson, B. A., Allen, A. C., & Bryson, S. (2011). The role of prenatal, obstetric and neonatal factors in the development of autism. Journal of Autism and Developmental Disorders, 41, 891–902.PubMedCrossRefGoogle Scholar
  19. Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629–634.PubMedCentralPubMedCrossRefGoogle Scholar
  20. Eidelman, A. I., & Samueloff, A. (2002). The pathophysiology of the fetus of the diabetic mother. Seminars in Perinatology, 26, 232–236.PubMedCrossRefGoogle Scholar
  21. Elhameed, M. A. A., Elbaky, A. E. O. A., & Kamel, E. A. (2011). A controlled study of the risk factors and clinical picture of children with autism in an Egyptian sample. Egypt Journal of Neurology, Neurosurgery and Psychiatry, 48, 271–276.Google Scholar
  22. Fernandez-Morera, J. L., Rodriguez-Rodero, S., Menendez-Torre, E., & Fraga, M. F. (2010). The possible role of epigenetics in gestational diabetes: Cause, consequence, or both. Obstetrics and Gynecology International, 2010, 605163.PubMedCentralPubMedCrossRefGoogle Scholar
  23. Ferrara, A. (2007). Increasing prevalence of gestational diabetes mellitus: A public health perspective. Diabetes Care, 30(Suppl 2), S141–S146.PubMedCrossRefGoogle Scholar
  24. Gardener, H., Spiegelman, D., & Buka, S. L. (2009). Prenatal risk factors for autism: Comprehensive meta-analysis. British Journal of Psychiatry, 195, 7–14.PubMedCentralPubMedCrossRefGoogle Scholar
  25. Gardener, H., Spiegelman, D., & Buka, S. L. (2011). Perinatal and neonatal risk factors for autism: A comprehensive meta-analysis. Pediatrics, 128, 344–355.PubMedCentralPubMedCrossRefGoogle Scholar
  26. Georgieff, M. K. (2006). The effect of maternal diabetes during pregnancy on the neurodevelopment of offspring. Minnesota Medicine, 89, 44–47.PubMedGoogle Scholar
  27. Gillberg, C. (1999). Neurodevelopmental processes and psychological functioning in autism. Development and Psychopathology, 11, 567–587.PubMedCrossRefGoogle Scholar
  28. Guinchat, V., Thorsen, P., Laurent, C., Cans, C., Bodeau, N., & Cohen, D. (2012). Pre-, peri- and neonatal risk factors for autism. Acta Obstetricia et Gynecologica Scandinavica, 91, 287–300.PubMedCrossRefGoogle Scholar
  29. Hayes, D. K., Fan, A. Z., Smith, R. A., & Bombard, J. M. (2011). Trends in selected chronic conditions and behavioral risk factors among women of reproductive age, behavioral risk factor surveillance system, 2001–2009. Preventing Chronic Disease, 8, A120.PubMedCentralPubMedGoogle Scholar
  30. Herrera, E., & Ortega-Senovilla, H. (2010). Disturbances in lipid metabolism in diabetic pregnancy: Are these the cause of the problem? Best Practice and Research Clinical Endocrinology and Metabolism, 24, 515–525.PubMedCrossRefGoogle Scholar
  31. Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21, 1539–1558.PubMedCrossRefGoogle Scholar
  32. Huerta, J. M., Tormo, M. J., Egea-Caparros, J. M., Ortola-Devesa, J. B., & Navarro, C. (2009). Accuracy of self-reported diabetes, hypertension and hyperlipidemia in the adult Spanish population. DINO study findings. Revista Espanola de Cardiologia, 62, 143–152.PubMedCrossRefGoogle Scholar
  33. Hultman, C. M., Sparen, P., & Cnattingius, S. (2002). Perinatal risk factors for infantile autism. Epidemiology, 13, 417–423.PubMedCrossRefGoogle Scholar
  34. International Diabetes Federation. (2013) IDF Policy Briefing: Diabetes in Pregnancy: Protecting Maternal Health. Accessed July 10, 2013, from http://www.idf.org/sites/default/files/Policy_Briefing_DiabetesInPregancy.pdf.
  35. Juul-Dam, N., Townsend, J., & Courchesne, E. (2001). Prenatal, perinatal, and neonatal factors in autism, pervasive developmental disorder-not otherwise specified, and the general population. Pediatrics, 107, E63.PubMedCrossRefGoogle Scholar
  36. Keil, A., Daniels, J. L., Forssen, U., Hultman, C., Cnattingius, S., Soderberg, K. C., et al. (2010). Parental autoimmune diseases associated with autism spectrum disorders in offspring. Epidemiology, 21, 805–808.PubMedCentralPubMedCrossRefGoogle Scholar
  37. Kolevzon, A., Gross, R., & Reichenberg, A. (2007). Prenatal and perinatal risk factors for autism: a review and integration of findings. Archives of Pediatrics and Adolescent Medicine, 161, 326–333.PubMedCrossRefGoogle Scholar
  38. Krakowiak, P., Walker, C. K., Bremer, A. A., Baker, A. S., Ozonoff, S., Hansen, R. L., et al. (2012). Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics, 129, e1121–e1128.PubMedCentralPubMedCrossRefGoogle Scholar
  39. Leonard, H., de Klerk, N., Bourke, J., & Bower, C. (2006). Maternal health in pregnancy and intellectual disability in the offspring: A population-based study. Annals of Epidemiology, 16, 448–454.PubMedCrossRefGoogle Scholar
  40. Levy, S. E., Mandell, D. S., & Schultz, R. T. (2009). Autism. Lancet, 374, 1627–1638.CrossRefGoogle Scholar
  41. London, E. A. (2000). The environment as an etiologic factor in autism: A new direction for research. Environmental Health Perspectives, 108(Suppl 3), 401–404.PubMedCentralPubMedGoogle Scholar
  42. Lyall, K., Pauls, D. L., Spiegelman, D., Ascherio, A., & Santangelo, S. L. (2012). Pregnancy complications and obstetric suboptimality in association with autism spectrum disorders in children of the Nurses’ Health Study II. Autism Research, 5, 21–30.PubMedCentralPubMedCrossRefGoogle Scholar
  43. Ming, X., Stein, T. P., Brimacombe, M., Johnson, W. G., Lambert, G. H., & Wagner, G. C. (2005). Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukotrienes and Essential Fatty Acids, 73, 379–384.CrossRefGoogle Scholar
  44. National Institute for Health and Care Excellence. (2009). NICE clinical guidelines 63: Diabetes in pregnancy: Management of diabetes and its complications from pre-conception to the postnatal period. Accessed July 10, 2013, from http://guidance.nice.org.uk/CG63.
  45. Newschaffer, C. J., Croen, L. A., Daniels, J., Giarelli, E., Grether, J. K., Levy, S. E., et al. (2007). The epidemiology of autism spectrum disorders. Annual Review of Public Health, 28, 235–258.PubMedCrossRefGoogle Scholar
  46. Okura, Y., Urban, L. H., Mahoney, D. W., Jacobsen, S. J., & Rodeheffer, R. J. (2004). Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. Journal of Clinical Epidemiology, 57, 1096–1103.PubMedCrossRefGoogle Scholar
  47. Onore, C., Careaga, M., & Ashwood, P. (2012). The role of immune dysfunction in the pathophysiology of autism. Brain, Behavior, and Immunity, 26, 383–392.PubMedCentralPubMedCrossRefGoogle Scholar
  48. Ornoy, A., Ratzon, N., Greenbaum, C., Wolf, A., & Dulitzky, M. (2001). School-age children born to diabetic mothers and to mothers with gestational diabetes exhibit a high rate of inattention and fine and gross motor impairment. Journal of Pediatric Endocrinology and Metabolism, 14(Suppl 1), 681–689.PubMedGoogle Scholar
  49. Piven, J., Simon, J., Chase, G. A., Wzorek, M., Landa, R., Gayle, J., et al. (1993). The etiology of autism: Pre-, peri- and neonatal factors. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1256–1263.PubMedCrossRefGoogle Scholar
  50. Rapin, I. (2002). The autistic-spectrum disorders. New England Journal of Medicine, 347, 302–303.PubMedCrossRefGoogle Scholar
  51. Rizzo, T. A., Dooley, S. L., Metzger, B. E., Cho, N. H., Ogata, E. S., & Silverman, B. L. (1995). Prenatal and perinatal influences on long-term psychomotor development in offspring of diabetic mothers. American Journal of Obstetrics and Gynecology, 173, 1753–1758.PubMedCrossRefGoogle Scholar
  52. Rodier, P. M., Ingram, J. L., Tisdale, B., Nelson, S., & Romano, J. (1996). Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. Journal of Comparative Neurology, 370, 247–261.PubMedCrossRefGoogle Scholar
  53. Schanen, N. C. (2006). Epigenetics of autism spectrum disorders. Hum Mol Genet, 15(2), R138–R150.PubMedCrossRefGoogle Scholar
  54. Solomon, C. G., Willett, W. C., Carey, V. J., Rich-Edwards, J., Hunter, D. J., Colditz, G. A., et al. (1997). A prospective study of pregravid determinants of gestational diabetes mellitus. The Journal of the American Medical Association, 278, 1078–1083.CrossRefGoogle Scholar
  55. Stern, M. (2011). Insulin signaling and autism. Frontiers in Endocrinology, 2, 54.PubMedCentralPubMedCrossRefGoogle Scholar
  56. Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., et al. (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. The Journal of the American Medical Association, 283, 2008–2012.CrossRefGoogle Scholar
  57. Van den Bergh, B. R. (2011). Developmental programming of early brain and behaviour development and mental health: a conceptual framework. Developmental Medicine and Child Neurology, 53(Suppl 4), 19–23.PubMedCrossRefGoogle Scholar
  58. Wells, G. A., Shea, B., O’Connell, D., Peterson, J., Welch, V., Losos, M., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Accessed January 30, 2013, from http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
  59. Wong, V. C., & Hui, S. L. (2008). Epidemiological study of autism spectrum disorder in China. Journal of Child Neurology, 23, 67–72.PubMedCrossRefGoogle Scholar
  60. Yao, Y., Walsh, W. J., McGinnis, W. R., & Pratico, D. (2006). Altered vascular phenotype in autism: correlation with oxidative stress. Archives of Neurology, 63, 1161–1164.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York (outside the USA) 2013

Authors and Affiliations

  1. 1.Department of Maternal and Child Health, School of Public HealthSun Yat-Sen UniversityGuangzhouChina
  2. 2.Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical CenterUniversity of Cincinnati College of MedicineCincinnatiUSA
  3. 3.Epidemiology Branch, Division of Epidemiology, Statistics, and Prevention Research, Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institutes of HealthRockvilleUSA

Personalised recommendations